Centene

CNC

Market cap $33.7B

Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.

ST. LOUIS, July 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m.

Centene Corporation's CNC margin recovery story appears to be shifting from strategy to execution. The company has rolled out several initiatives to better manage medical costs, modernize and standardize processes, and strengthen payment integrity.

ST. LOUIS, July 9, 2026 /PRNewswire/ -- Centene Corporation (Centene) (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid managed care program. The four-year contract is expected to begin January 1, 2027, through 2030.

CNC expands AI-driven fraud prevention and payment integrity to improve Medicaid margins, boost cost controls and support long-term earnings growth.

Centene has surged over 150% since my upgrade, driven by robust Q1 results and margin improvements. Medicaid and Medicare Advantage performance exceeded expectations, with management reaffirming a 2027 breakeven target for Medicare Advantage. CNC's balance sheet has strengthened, with reduced debt and $1.8 billion remaining for share buybacks, supporting further capital allocation flexibility.

Centene offers a defensive shelter as the AI infrastructure market faces skepticism and volatility. ACA insurance exchanges suffered adverse selection as healthy individuals exited, leaving a sicker, costlier pool. Regulatory shifts and flawed industry algorithms led to unexpected losses for insurers unable to adjust patient mix.

CNC's integrated healthcare model, AI-driven operations and improving Medicaid margins are strengthening earnings as the company raises 2026 EPS guidance.

CLS, CBOE, and CNC it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2026.

CBOE, CNC and CRDO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 25th, 2026.